Immunotherapy and chemotherapy — a practical partnership
Top Cited Papers
- 20 April 2005
- journal article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 5 (5) , 397-405
- https://doi.org/10.1038/nrc1613
Abstract
This article discusses how recent data have altered the way we understand how dying tumour cells, particularly those killed by chemotherapy, engage with antitumour immune responses. These data have significant implications for the development of new protocols combining chemotherapy with immunotherapy, indicating an exciting potential for therapeutic synergy with general applicability to many cancer types.Keywords
This publication has 64 references indexed in Scilit:
- Life after corpse engulfment: phagocytosis of apoptotic cells leads to VEGF secretion and cell growthThe FASEB Journal, 2004
- A listing of human tumor antigens recognized by T cells: March 2004 updateCancer Immunology, Immunotherapy, 2004
- CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curativeEuropean Journal of Immunology, 2004
- A decade of caspasesOncogene, 2003
- Molecular identification of a danger signal that alerts the immune system to dying cellsNature, 2003
- The immune system evolved to discriminate infectious nonself from noninfectious selfPublished by Elsevier ,2003
- Interaction of Heat Shock Proteins with Peptides and Antigen Presenting Cells: Chaperoning of the Innate and Adaptive Immune ResponsesAnnual Review of Immunology, 2002
- Consequences of Cell DeathThe Journal of Experimental Medicine, 2000
- LIGAND RECOGNITION BY αβ T CELL RECEPTORSAnnual Review of Immunology, 1998
- Tolerance, Danger and the Extended FamilyAnnual Review of Immunology, 1994